shutterstock_1696929460_m_foto

M-Foto / Shutterstock.com

12 August 2021AmericasAlex Baldwin

Brazil passes compulsory licence bill for COVID-19 vaccines

The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Brazil Supreme Court suspends drug patent extensions

8 April 2021 Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

More on this story

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Brazil Supreme Court suspends drug patent extensions

8 April 2021 Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

More on this story

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Brazil Supreme Court suspends drug patent extensions

8 April 2021 Brazil’s highest court has suspended extensions of drug patents due to the public health emergency caused by COVID-19.

More features

President Trump 2.0: Five major areas to watch

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

New president’s to-do list: Patent bills, non-competes, USPTO director?

Sanofi subsidiary fends off $450m trade secrets case

Regulatory expert joins White & Case

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?